Form 4: Amgen EVP & CFO Peter H. Griffith Reports Acquisition of Common Stock

Peter H. Griffith, EVP & CFO of Amgen Inc., reports acquiring 7,277 shares of common stock on March 3, 2025.

Summary

• Peter H. Griffith, the EVP & CFO of Amgen Inc., filed a Form 4 on March 5, 2025, reporting a transaction.
• On March 3, 2025, Griffith acquired 7,277 shares of Amgen common stock.
• The acquisition price was $0 per share.
• Following the transaction, Griffith directly owns 43,502 shares of Amgen common stock.
• The reported shares include 678 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it's a standard disclosure of stock acquisition by an executive. It doesn't inherently indicate positive or negative sentiment about the company's future.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to gauge management's sentiment and confidence in the company's prospects.

Stakeholder Impact

• The acquisition of shares by a high-ranking executive could be perceived positively by shareholders, signaling confidence in the company's future performance.

Key Dates